57O A phase I/II multicenter, first-in-human study of DB-1311/BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors. - Cheng, Y.; Wu, L.; Parsonson, A.; Amin, H.; Shi, J.; Lemech, C.; Sun, Y.; Schmidt, A.; Lv, D.; Li, M.; Zheng, T.; Chaudhry, A.; et al. (Annals of Oncology, 2024)